1. Kohn LT, Corrigan J, Donaldson MS. Institute of Medicine (US) Committee on Quality of Health Care in America. To error is human: building a safer health system. 1999. Washington, DC: National Academy Press.
2. Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions. Am J Health Syst Pharm. 1998. 55:165–166.
3. Manasse HR Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 2. Am J Hosp Pharm. 1989. 46:1141–1152.
Article
4. Korean Society for Pharmacoepidemiology and Risk Management. Pharmacoepidemiology. 2011. Seoul: Seoul National University Press.
5. Woo CM. Guidelines on medication error prevention. 2008. Seoul: Ministry of Health and Welfare.
6. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004. 329:15–19.
Article
7. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997. 277:301–306.
Article
8. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL. Adverse Drug Events Prevention Study Group. The costs of adverse drug events in hospitalized patients. JAMA. 1997. 277:307–311.
Article
9. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med. 1997. 157:2089–2096.
Article
10. White TJ, Arakelian A, Rho JP. Counting the costs of drug-related adverse events. Pharmacoeconomics. 1999. 15:445–458.
Article
11. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001. 41:192–199.
Article
12. Rich DS. A process for interpreting data on adverse drug events: determining optimal target levels. Clin Ther. 1998. 20:Suppl C. C59–C71.
Article
13. Coleman IC. Medication errors: picking up the pieces. Drug Top. 1999. 143:83–92.
14. Aspden P. Institute of Medicine (US) Committee on Identify-ing and Preventing Medication Errors. Preventing medication errors. 2006. Washington, DC: National Academy Press.
15. Shin HT. Separation of dispensing and prescribing function : assessment and ways for improvement. A policy debate at the National Assembly. 2011. 05. 04. Seoul, Korea:
16. ASHP guidelines on preventing medication errors in hospitals. Am J Hosp Pharm. 1993. 50:305–314.
17. Barker KN, Flynn EA, Pepper GA, Bates DW, Mikeal RL. Medication errors observed in 36 health care facilities. Arch Intern Med. 2002. 162:1897–1903.
Article
18. Hartwig SC, Denger SD, Schneider PJ. Severity-indexed, incident report-based medication error-reporting program. Am J Hosp Pharm. 1991. 48:2611–2616.
Article
19. Dunn EB, Wolfe JJ. Medication error classification and avoidance. Hosp Pharm. 1997. 32:860–865.
20. Han HJ. Prevention and management of medication errors. J Korean Soc Health Syst Pharm. 2005. 22:173–180.
21. Malone PM, Wilkinson MK, Kier KL, Stanovich JE. Drug information: a guide for pharmacists. 2001. 2nd ed. New York: McGraw-Hill.
22. Son IJ. Guidelines on medication error management in Seoul National University Hospital. J Korean Soc Health Syst Pharm. 2003. 20:180–182.
23. Lee EK, et al. Development of risk management system to assure drug safety. 2005. Seoul: Ministry of Health and Welfare.
24. Sohn IJ. A pilot study on medication error management in hospitals. 2006. Seoul: Ministry of Health and Welfare.
25. Kang SK. Excessive accusation of dispensing errors, not desirable. Dailypharm. 2009. 04.
26. Harsh administrative measures against improper dose error. Dailypharm. 2009. 07. 27.